Atwood & Palmer’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-750
| Closed | -$29.5K | – | 437 |
|
|
2023
Q2 | $29.5K | Hold |
750
| – | – | ﹤0.01% | 247 |
|
|
2023
Q1 | $18.2K | Hold |
750
| – | – | ﹤0.01% | 269 |
|
|
2022
Q4 | $16.1K | Hold |
750
| – | – | ﹤0.01% | 298 |
|
|
2022
Q3 | $13K | Hold |
750
| – | – | ﹤0.01% | 295 |
|
|
2022
Q2 | $7K | Hold |
750
| – | – | ﹤0.01% | 348 |
|
|
2022
Q1 | $13K | Hold |
750
| – | – | ﹤0.01% | 354 |
|
|
2021
Q4 | $13K | Hold |
750
| – | – | ﹤0.01% | 358 |
|
|
2021
Q3 | $12K | Hold |
750
| – | – | ﹤0.01% | 347 |
|
|
2021
Q2 | $5K | Hold |
750
| – | – | ﹤0.01% | 371 |
|
|
2021
Q1 | $5K | Hold |
750
| – | – | ﹤0.01% | 390 |
|
|
2020
Q4 | $5K | Hold |
750
| – | – | ﹤0.01% | 346 |
|
|
2020
Q3 | $4K | Hold |
750
| – | – | ﹤0.01% | 303 |
|
|
2020
Q2 | $4K | Hold |
750
| – | – | ﹤0.01% | 296 |
|
|
2020
Q1 | $3K | Hold |
750
| – | – | ﹤0.01% | 300 |
|
|
2019
Q4 | $6K | Hold |
750
| – | – | ﹤0.01% | 269 |
|
|
2019
Q3 | $1K | Hold |
750
| – | – | ﹤0.01% | 297 |
|
|
2019
Q2 | $1K | Hold |
750
| – | – | ﹤0.01% | 295 |
|
|
2019
Q1 | $1K | Hold |
750
| – | – | ﹤0.01% | 324 |
|
|
2018
Q4 | $1K | Hold |
750
| – | – | ﹤0.01% | 315 |
|
|
2018
Q3 | $2K | Hold |
750
| – | – | ﹤0.01% | 301 |
|
|
2018
Q2 | $2K | Hold |
750
| – | – | ﹤0.01% | 301 |
|
|
2018
Q1 | $2K | Hold |
750
| – | – | ﹤0.01% | 281 |
|
|
2017
Q4 | $2K | Hold |
750
| – | – | ﹤0.01% | 281 |
|
|
2017
Q3 | $2K | Hold |
750
| – | – | ﹤0.01% | 288 |
|
|
2017
Q2 | $2K | Hold |
750
| – | – | ﹤0.01% | 307 |
|
|
2017
Q1 | $3K | Hold |
750
| – | – | ﹤0.01% | 277 |
|
|
2016
Q4 | $4K | Buy |
+750
| New | +$22.3K | ﹤0.01% | 298 |
|
Atwood & Palmer's ISEE Position: Q3 2023 in Review
Atwood & Palmer sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 750 shares — an estimated $29.5K sold.
Atwood & Palmer first reported a position in ISEE in Q4 2016 and held it in 27 quarters. The position peaked at $29.5K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Atwood & Palmer reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Atwood & Palmer sold 750 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $29.5K.
- Atwood & Palmer first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 27 quarters.
- Atwood & Palmer's IVERIC bio, Inc. Common Stock position peaked at $29.5K in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Atwood & Palmer's 13F filing for Q3 2023, filed 20 Oct 2023.